Trials / Completed
CompletedNCT02418871
Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) With an Improved Injector System
Clinical Evaluation of the FluidVision Accommodating Intraocular Lens With an Improved Injector System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- PowerVision · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the clinical outcomes of an investigational IOL in patients undergoing cataract extraction and intraocular lens implantation using an improved injector system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FluidVision AIOL | Investigational implantable medical device intended for long-term use over the lifetime of the cataract subject. An improved injector system was used. |
| PROCEDURE | Cataract surgery | Performed using standard microsurgical techniques |
Timeline
- Start date
- 2015-03-13
- Primary completion
- 2016-03-16
- Completion
- 2018-09-05
- First posted
- 2015-04-16
- Last updated
- 2021-05-21
Locations
5 sites across 2 countries: Hungary, South Africa
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02418871. Inclusion in this directory is not an endorsement.